Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

Heptares Founder Shares Her Best Life Sciences Career Advice

  • Post author:Sam
  • Post published:November 21, 2017
  • Post category:BioPharma

Fiona Marshall founded Heptares Therapeutics, which is now one of the leading biotech companies in the UK. Source: BioSpace

Continue ReadingHeptares Founder Shares Her Best Life Sciences Career Advice

Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to …

  • Post author:Sam
  • Post published:November 21, 2017
  • Post category:BioPharma

Puma will receive upfront and milestone payments of up to $4.5 million throughout the term of this agreement. Source: BioSpace

Continue ReadingPuma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to …

AmerisourceBergen Pays $815M Cash for Drug Wholesaler H. D. Smith

  • Post author:Sam
  • Post published:November 20, 2017
  • Post category:BioPharma

AmerisourceBergen expects the transaction to slightly add to its adjusted earnings per share in the current fiscal year. Source: BioSpace

Continue ReadingAmerisourceBergen Pays $815M Cash for Drug Wholesaler H. D. Smith

Meet the Under-the-Radar Biotech With a 'Novel' Alzheimer's Candidate

  • Post author:Sam
  • Post published:November 20, 2017
  • Post category:BioPharma

As the world watches big pharma companies take on the challenges of developing a viable therapy for ALZ’s disease, smaller companies are also attempting to blaze a treatment trail in…

Continue ReadingMeet the Under-the-Radar Biotech With a 'Novel' Alzheimer's Candidate

Biogen Taps Biotech Vet as New CFO

  • Post author:Sam
  • Post published:November 20, 2017
  • Post category:BioPharma

Mr. Capello will lead Biogen’s Business Planning, Tax, Treasury, Internal Audit, Accounting, and Investor Relations functions. Source: BioSpace

Continue ReadingBiogen Taps Biotech Vet as New CFO

Tiny Corbus Aims to Have Four Drugs in Mid- to Late-Stage Development by Next Year

  • Post author:Sam
  • Post published:November 20, 2017
  • Post category:BioPharma

In less than four years, Corbus has grown from a tiny startup to a public company with 60 employees and four assets in the clinic. Source: BioSpace

Continue ReadingTiny Corbus Aims to Have Four Drugs in Mid- to Late-Stage Development by Next Year

Palatin Forges $40.5M+ Deal With Korea's Kwangdong Pharma

  • Post author:Sam
  • Post published:November 20, 2017
  • Post category:BioPharma

Palatin has entered into a deal with Kwangdong, for exclusive rights to develop and commercialize bremelanotide for female sexual dysfunction indications in the Republic of Korea. Source: BioSpace

Continue ReadingPalatin Forges $40.5M+ Deal With Korea's Kwangdong Pharma

3 Biotechs That Have Investors Grinning at Thanksgiving Dinner This Year

  • Post author:Sam
  • Post published:November 20, 2017
  • Post category:BioPharma

Investors have had a decent year, but some have much to be grateful for this Thanksgiving. Source: BioSpace

Continue Reading3 Biotechs That Have Investors Grinning at Thanksgiving Dinner This Year

Cytokinetics Scraps Lead ALS Drug After Late-Stage Trial Failure

  • Post author:Sam
  • Post published:November 20, 2017
  • Post category:BioPharma

Cytokinetics said it has suspended development of tirasemtiv after it failed to differentiate itself from placebo in a statistically significant manner. Source: BioSpace

Continue ReadingCytokinetics Scraps Lead ALS Drug After Late-Stage Trial Failure

Stanford, NCI Researchers Discover New CAR-T Target With Early Study Data

  • Post author:Sam
  • Post published:November 20, 2017
  • Post category:BioPharma

Instead of targeting a molecule called CD19 on the surface of the cancer cells, the new therapy targets a molecule called CD22. Source: BioSpace

Continue ReadingStanford, NCI Researchers Discover New CAR-T Target With Early Study Data
  • Go to the previous page
  • 1
  • …
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.